These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
228 related items for PubMed ID: 24552888
1. Racial differences in incident atrial fibrillation among hypertensive patients during antihypertensive therapy. Okin PM, Bang CN, Wachtell K, Hille DA, Kjeldsen SE, Julius S, Dahlöf B, Devereux RB. Am J Hypertens; 2014 Jul; 27(7):966-72. PubMed ID: 24552888 [Abstract] [Full Text] [Related]
2. Regression of electrocardiographic left ventricular hypertrophy and decreased incidence of new-onset atrial fibrillation in patients with hypertension. Okin PM, Wachtell K, Devereux RB, Harris KE, Jern S, Kjeldsen SE, Julius S, Lindholm LH, Nieminen MS, Edelman JM, Hille DA, Dahlöf B. JAMA; 2006 Sep 13; 296(10):1242-8. PubMed ID: 16968848 [Abstract] [Full Text] [Related]
3. Relationship of sudden cardiac death to new-onset atrial fibrillation in hypertensive patients with left ventricular hypertrophy. Okin PM, Bang CN, Wachtell K, Hille DA, Kjeldsen SE, Dahlöf B, Devereux RB. Circ Arrhythm Electrophysiol; 2013 Apr 13; 6(2):243-51. PubMed ID: 23403268 [Abstract] [Full Text] [Related]
6. Racial differences in sudden cardiac death among hypertensive patients during antihypertensive therapy: the LIFE study. Okin PM, Kjeldsen SE, Julius S, Dahlöf B, Devereux RB. Heart Rhythm; 2012 Apr 13; 9(4):531-7. PubMed ID: 22079554 [Abstract] [Full Text] [Related]
7. Electrocardiographic left atrial abnormalities and risk of incident stroke in hypertensive patients with electrocardiographic left ventricular hypertrophy. Okin PM, Kamel H, Kjeldsen SE, Devereux RB. J Hypertens; 2016 Sep 13; 34(9):1831-7. PubMed ID: 27254312 [Abstract] [Full Text] [Related]
8. Regression of electrocardiographic left ventricular hypertrophy is associated with less hospitalization for heart failure in hypertensive patients. Okin PM, Devereux RB, Harris KE, Jern S, Kjeldsen SE, Julius S, Edelman JM, Dahlöf B, LIFE Study Investigators. Ann Intern Med; 2007 Sep 04; 147(5):311-9. PubMed ID: 17785486 [Abstract] [Full Text] [Related]
9. Impact of alcohol habits and smoking on the risk of new-onset atrial fibrillation in hypertensive patients with ECG left ventricular hypertrophy: the LIFE study. Ariansen I, Reims HM, Gjesdal K, Olsen MH, Ibsen H, Devereux RB, Okin PM, Kjeldsen SE, Dahlöf B, Wachtell K. Blood Press; 2012 Feb 04; 21(1):6-11. PubMed ID: 22070095 [Abstract] [Full Text] [Related]
10. Regression of electrocardiographic left ventricular hypertrophy during antihypertensive treatment and the prediction of major cardiovascular events. Okin PM, Devereux RB, Jern S, Kjeldsen SE, Julius S, Nieminen MS, Snapinn S, Harris KE, Aurup P, Edelman JM, Wedel H, Lindholm LH, Dahlöf B, LIFE Study Investigators. JAMA; 2004 Nov 17; 292(19):2343-9. PubMed ID: 15547161 [Abstract] [Full Text] [Related]
16. Psoriasis is associated with subsequent atrial fibrillation in hypertensive patients with left ventricular hypertrophy: the Losartan Intervention For Endpoint study. Bang CN, Okin PM, Køber L, Wachtell K, Gottlieb AB, Devereux RB. J Hypertens; 2014 Mar 17; 32(3):667-72. PubMed ID: 24379001 [Abstract] [Full Text] [Related]
17. In-treatment reduced left atrial diameter during antihypertensive treatment is associated with reduced new-onset atrial fibrillation in hypertensive patients with left ventricular hypertrophy: The LIFE Study. Wachtell K, Gerdts E, Aurigemma GP, Boman K, Dahlöf B, Nieminen MS, Olsen MH, Okin PM, Palmieri V, Rokkedal JE, Devereux RB. Blood Press; 2010 Jun 17; 19(3):169-75. PubMed ID: 20438307 [Abstract] [Full Text] [Related]